An analysis of the actual government spending for Medicare Part D as a percentage of total program costs in comparison to the government’s legislated subsidy target of 74.5%. The 74.5% target is made up of direct subsidy payments and reinsurance claims.

This report was commissioned by The Pharmaceutical Research and Manufacturers of America (PhRMA).